跳至主要内容
临床试验/TCTR20220527002
TCTR20220527002招募中不适用

The comparison of success rate of treatment of Graves disease with fixed dose radioiodine therapy between protocol 1 and protocol 2 in EEC region

Queen Savang Memorial Vadhana Hospital0 个研究点目标入组 650 人开始时间: 2022年5月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
650

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. the patient was diagnosed as Graves disease and getted indication for radioiodine therapy including thyroid strom, thyrotoxicosis periodic paralysis, side effects from anti-thyroid drugs and relapse ,recurrent or incomplete remission of Graves disease.
  • 2. No contraindication for radioiodine therapy including pregnancy, lactation, moderate-to-severe Graves opthalmopathy.
  • 3. patient hadn't been treated with radioiodine therapy.

排除标准

  • 1. loss-to-follow up is less than 5 months.

研究者

相似试验